US Drug Recall Register

FDA Drug Recalls

11,815 recalls · Class II, newest first

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 2026202520242023
Class II · Moderate risk Terminated

dilTIAZem added to dextrose 5%

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 72185-6054-1 D-0712-2023
Class II · Moderate risk Terminated

oxyTOCIN 60 units added to 0.9% sodium chloride 1

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-6045-1 D-0711-2023
Class II · Moderate risk Terminated

oxyTOCIN 30 units added to 0.9% sodium chloride 500 mL per bag

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-6044-1 D-0710-2023
Class II · Moderate risk Terminated

oxyTOCIN 20 units added to 0.9% sodium chloride 1

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 72185-6043-1 D-0709-2023
Class II · Moderate risk Terminated

oxyTOCIN 15 units added to 0.9% sodium chloride 250 mL per bag

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 72185-6042-1 D-0708-2023
Class II · Moderate risk Terminated

oxyTOCIN 30 units added to Lactated Ringer's 500 mL per bag

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-6039-1 D-0707-2023
Class II · Moderate risk Terminated

oxyTOCIN 20 units added to Lactated Ringer's 1

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-6038-1 D-0706-2023
Class II · Moderate risk Terminated

oxyTOCIN 15 units added to Lactated Ringer's 250 mL per bag

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-6037-1 D-0705-2023
Class II · Moderate risk Terminated

oxyTOCIN 10 units added to Lactated Ringer's 500 mL per bag

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 72185-6036-1 D-0704-2023
Class II · Moderate risk Terminated

oxyTOCIN 20 units added to dextrose 5%/Lactated Ringer's 1

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-6031-1 D-0702-2023
Class II · Moderate risk Terminated

EPINEPHrine added to dextrose 5%

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-6030-1 D-0701-2023
Class II · Moderate risk Terminated

Neonatal TPN Starter Bag

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0432-1 D-0700-2023
Class II · Moderate risk Terminated

Neonatal TPN Starter Bag

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0430-1 D-0699-2023
Class II · Moderate risk Terminated

Neonatal PN Starter Bag

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0429-1 D-0698-2023
Class II · Moderate risk Terminated

Neonatal TPN Starter Bag

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0428-1 D-0697-2023
Class II · Moderate risk Terminated

Neonatal TPN Starter Bag

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0427-1 D-0696-2023
Class II · Moderate risk Terminated

Neonatal TPN Starter Bag

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0425-1 D-0695-2023
Class II · Moderate risk Terminated

Neonatal TPN Starter Bag

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0423-1 D-0694-2023
Class II · Moderate risk Terminated

Neonatal TPN Starter Bag

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0422-1 D-0693-2023
Class II · Moderate risk Terminated

Neonatal TPN Starter Bag

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0421-1 D-0692-2023
Class II · Moderate risk Terminated

Neonatal TPN Starter Bag

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0420-1 D-0691-2023
Class II · Moderate risk Terminated

Neonatal TPN Starter Bag

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0419-1 D-0690-2023
Class II · Moderate risk Terminated

Neonatal TPN Starter Bag

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0418-1 D-0689-2023
Class II · Moderate risk Terminated

Neonatal TPN Starter Bag

Reason Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Central Admixture Pharmacy Services, Inc. NDC 71285-0416-1 D-0688-2023